KIF18B promotes tumor progression through activating the Wnt/β-catenin pathway in cervical cancer
Cited by 73
Related Papers
Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
|The Lancet Respiratory Medicine|2021|183
Genetic Risk for Overall Cancer and the Benefit of Adherence to a Healthy Lifestyle
|Cancer Research|2021|121
A novel lncRNA, LUADT1, promotes lung adenocarcinoma proliferation via the epigenetic suppression of p27
|Cell Death and Disease|2015|112